Wednesday, July 8, 2026

pharma · Glioblastoma, IDH-wildtype · SHPH

Shuttle Pharmaceuticals Holdings

Shuttle Pharmaceuticals Holdings trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Rockville, USA HQ
2012 Founded
5 Employees
Public company Type
SHPH · NYSE Ticker
Company details
Status
Public
HQ
Rockville, USA
Founded
2012
Employees
5
Programs
1
Drugs
1
Patents
9
Intelligence · Clinical Trials

Shuttle Pharmaceuticals Holdings clinical trials

Registry index of 1 ClinicalTrials.gov studies linked to Shuttle Pharmaceuticals Holdings programs — each row shows trial ID, program name, phase, status, and indication.

Shuttle Pharmaceuticals Holdings trial registry — 1 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Shuttle Pharmaceuticals Holdings.

  1. Ropidoxuridine — Phase 2

    Clinical update
  2. Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

    Patent grant
  3. Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

    Patent grant
  4. Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof

    Patent grant

Trial registry

1 studies